# Kiniksa Pharmaceuticals International, plc (KNSA) - Q4 2025 earnings

Reported February 24, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | $202.1M | $200.8M |
| EPS | $0.17 | $0.29 |

Earnings filing reader: [8-K 0001730430-26-000014](https://www.opencapital.sh/filings/0001730430-26-000014)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001730430-26-000014.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1730430/000173043026000014/0001730430-26-000014-index.htm)
Periodic report: 10-K - https://www.sec.gov/Archives/edgar/data/1730430/000110465926019168/0001104659-26-019168-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/knsa/earnings/q4-2025